Histologically challenging melanocytic tumors referred to a tertiary care pigmented lesion clinic

Journal of the American Academy of Dermatology

Volumn 67, Issue 4, 2012, Pages 727-735

  Hawryluk, Elena B ^a   Sober, Arthur J ^a   Piris, Adriano ^a   Nazarian, Rosalynn M ^a   Hoang, Mai P ^a   Tsao, Hensin ^a   Mihm Jr , Martin C ^b   Duncan, Lyn M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

consensus; dermatopathology; melanocytic tumors; melanoma; pigmented lesions

Indexed keywords

BENIGN ACQUIRED NEVUS; CANCER STAGING; DYSPLASTIC NEVUS; HISTOLOGY; HUMAN; HUMAN TISSUE; JUVENILE MELANOMA; MAJOR CLINICAL STUDY; MALIGNANT LENTIGO; MEDICAL RECORD REVIEW; MELANOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SENTINEL LYMPH NODE BIOPSY;

EID: 84866366353     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2012.02.036     Document Type: Article

References (35)

1. W.H. Clark Jr., L. From, E.A. Bernardino, and M.C. Mihm The histogenesis and biologic behavior of primary human malignant melanomas of the skin Cancer Res 29 1969 705 727
2. A. Breslow Thickness, cross-sectional area and depth of invasion in the prognosis of cutaneous melanoma Ann Surg 172 1970 902 908
3. P.J. Heenan, L.R. Matz, J.B. Blackwell, G.R.H. Kelsall, A. Singh, and R.E. ten Seldam Inter-observer variation between pathologists in the classification of cutaneous malignant melanoma in Western Australia Histopathology 8 1984 717 729
4. C.P. Karakousis, L.J. Emrich, and U. Rao Tumor thickness and prognosis in clinical stage 1 malignant melanoma Cancer 64 1989 1432 1436
5. A.C. Buzaid, M.I. Ross, C.M. Balch, S. Soong, W.H. McCarthy, and L. Tinoco Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system [see comments] J Clin Oncol 15 1997 1039 1051
6. P.A. Gimotty, P. Van Belle, D.E. Elder, T. Murry, K.T. Montone, and X. Xu Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma J Clin Oncol 23 2005 8048 8056
7. A.B. Francken, H.M. Shaw, J.F. Thompson, S.J. Soong, N.A. Accortt, and M.F. Azzola The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up Ann Surg Oncol 11 2004 426 433
8. R.A. Scolyer, J.F. Thompson, H.M. Shaw, and S.W. McCarthy The importance of mitotic rate as a prognostic factor for localized primary cutaneous melanoma J Cutan Pathol 33 2006 395 396 author reply 397-9
9. W.H. Clark Jr., D.E. Elder, D. Guerry IV, M.N. Epstein, M.H. Greene, and M. Van Horn A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma Hum Pathol 15 1984 1147 1165
10. H.T. Lynch, B.C. Frichot, and J.F. Lynch Familial atypical multiple mole-melanoma syndrome J Med Genet 15 1978 352 356
11. A.R. Rhodes, T.J. Harrist, C.L. Day Jr., M.C. Mihm Jr., T.B. Fitzpatrick, and A.J. Sober Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas J Am Acad Dermatol 9 1983 563 574
12. C. Clemente, A.J. Cochran, D.E. Elder, A. Levene, R.M. MacKie, and M.C. Mihm Histopathologic diagnosis of dysplastic nevi: concordance among pathologists convened by the World Health Organization Melanoma Programme Hum Pathol 22 1991 313 319
13. R. Corona, A. Mele, M. Amini, G. De Rosa, G. Coppola, and P. Piccardi Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions J Clin Oncol 14 1996 1218 1223
14. P.E. de Wit, B. van't Hof-Grootenboer, D.J. Ruiter, R. Bondi, E.B. Brocker, and J.P. Cesarini Validity of the histopathological criteria used for diagnosing dysplastic naevi. An interobserver study by the pathology subgroup of the EORTC Malignant Melanoma Cooperative Group Eur J Cancer 29A 1993 831 839
15. L.M. Duncan, M. Berwick, J.A. Bruijn, H.R. Byers, M.C. Mihm Jr., and R.L. Barnhill Histopathologic recognition and grading of dysplastic melanocytic nevi: An interobserver agreement study J Invest Dermatol 100 1993 318S 321S
16. P.H. Duray, R. DerSimonian, R.L. Barnhill, K. Stenn, M.S. Ernstoff, and J. Fine An analysis of interobserver recognition of the histopathologic features of dysplastic nevi from a mixed group of nevomelanocytic lesions J Am Acad Dermatol 27 1992 741 749
17. M.W. Piepkorn The diagnostic reproducibility of melanocytic dysplasia Arch Dermatol 134 1998 1037 1038
18. E. Farmer, R. Gonin, and M. Hanna Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists Hum Pathol 27 1996 528 531
19. N. Hastrup, O. Clemmensen, E. Spaun, and K. Sondergaard Dysplastic nevus: histologic criteria and their inter-observer reproducibility Histopathology 24 1994 503 509
20. N. Krieger, R.A. Hiatt, R.W. Sagebiel, W.H. Clark Jr., and M.C. Mihm Jr. Inter-observer variability among pathologists' evaluation of malignant melanoma: effects upon an analytic study J Clin Epidemiol 47 1994 897 902
21. J. Lock-Andersen, K. Hou-Jensen, J.P. Hansen, N.K. Jensen, H. Sogaard, and P.K. Andersen Observer variation in histological classification of cutaneous malignant melanoma Scand J Plast Reconstr Hand Surg 29 1995 141 148
22. M.A. Weinstock, R.L. Barnhill, A.R. Rhodes, and G.L. Brodsky Reliability of the histopathologic diagnosis of melanocytic dysplasia Arch Dermatol 133 1997 953 958
23. P. Colloby, K. West, and A. Fletcher Observer variation in the measurement of Breslow depth and Clark's level in thin cutaneous malignant melanoma J Pathol 163 1991 245 250
24. C.M. Balch, J.E. Gershenwald, S.J. Soong, J.F. Thompson, M.D. Atkins, and D.R. Byrd Final version of 2009 AJCC melanoma staging and classification J Clin Oncol 27 2009 6199 6206
25. C. Bichakjian, A. Halpern, T. Johnson, A. Hood, J. Grichnik, and S. Swetter Guidelines of care for the management of primary cutaneous melanoma J Am Acad Dermatol 65 2011 1032 1047
26. C. Schmoeckel How consistent are dermatopathologists in reading early malignant melanomas and lesions "precursor" to them? An international survey Am J Dermatopathol 6 Suppl 1984 13 24
27. M.W. Piepkorn, R.L. Barnhill, L.A. Cannon-Albright, D.E. Elder, D.E. Goldgar, and C.M. Lewis A multiobserver, population-based analysis of histologic dysplasia in melanocytic nevi [see comment] J Am Acad Dermatol 30 1994 707 714
28. J. Frangos, L. Duncan, A. Piris, R. Nazarian, M. Mihm, and M. Hoang Increased diagnosis of thin superficial spreading melanomas: a 20-year study J Am Acad Dermatol 2011 Dec 7 [Epub ahead of print]
29. P.E. Boiko, and M.W. Piepkorn Reliability of skin biopsy pathology J Am Board Fam Pract 7 1994 371 374
30. T.E. Larsen, J.H. Little, S.R. Orell, and M. Prade International pathologists congruence survey on quantitation of malignant melanoma Pathology (Phila) 12 1980 245 253
31. A. Piris, M.C. Mihm Jr., and L.M. Duncan AJCC melanoma staging update: impact on dermatopathology practice and patient management J Cutan Pathol 38 2011 394 400
32. R.L. Barnhill, J. Katzen, A. Spatz, J. Fine, and M. Berwick The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma [see comment] J Cutan Pathol 32 2005 268 273
33. J.F. Thompson, S.J. Soong, C.M. Balch, J.E. Gershenwald, S. Ding, and D.G. Coit Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database J Clin Oncol 29 2011 2199 2205
34. S.B. Kesmodel, G.C. Karakousis, J.D. Botbyl, R.J. Canter, R.T. Lewis, and P.M. Wahl Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas Ann Surg Oncol 12 2005 449 458
35. M.F. Azzola, H.M. Shaw, J.F. Thompson, S.J. Soong, R.A. Scolyer, and G.F. Watson Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center Cancer 97 2003 1488 1498